Category: Nouvelles | Page 11

À l’heure du message I = I, comment parler des bienfaits du traitement anti-VIH pour la prévention au-delà des relations sexuelles?

28 avril 2021 • Par Mallory Harrigan

Le message I=I (indétectable égale intransmissible) est bien passé et est devenu un cri de ralliement pour les personnes et les organisations du monde entier : les personnes suivant un traitement anti-VIH efficace ne peuvent transmettre le virus à leurs partenaires sexuels. Ce message leur a ainsi permis d’avoir des relations sexuelles sans craindre de transmettre le virus, mais il a aussi contribué à combattre la stigmatisation. Bien que le message I=I ait eu le vent en poupe ces dernières années, le rôle du traitement anti-VIH visant à prévenir la transmission du virus par d’autres voies n’est pas encore bien connu....

Pour en savoir plus...

La prévention de la transmission du VIH pendant la pandémie de COVID-19 : Comment ça a commencé, comment ça se passe

28 avril 2021 • Par Mia Biondi et Kody Muncaster

Now, more than a year after the first Canadian COVID-19 case, we are struggling not just with a second, simultaneous pandemic in addition to HIV/AIDS, which has resulted in a change in the way people connect, engage in sexual activity and seek healthcare. This has an impact on how people access and take PrEP and has created a whole new set of challenges to address.

Pour en savoir plus...

From hesitance to confidence: ACCHO’s new COVID-19 vaccine video

22 avril 2021 • Par Wanjiru Munene and Ikran Ibrahim

The African and Caribbean Council on HIV/AIDS in Ontario (ACCHO) is a provincial coalition of organizations and individuals committed to HIV prevention, education, advocacy, research, treatment, care and support for African, Caribbean and Black (ACB) communities. They spoke to CATIE about the impact of COVID-19 in ACB communities, and their efforts to improve vaccine confidence.

Pour en savoir plus...

Prévenir le VIH pendant la pandémie de COVID-19 : la PPE et la « PPE dans la poche » à la rescousse

19 avril 2021 • Par le Dr Amila Heendeniya

HIV continues to be a global health threat, even amid the COVID-19 pandemic. In keeping with UNAIDS goals for reducing that burden, HIV prevention by PEP and PrEP have played major roles in reaching those goals. While PrEP has been instrumental in preventing HIV in people with high-risk exposures, we have seen gaps in HIV prevention strategies, especially among individuals who have less frequent exposures. This is where “pill-in-pocket PEP”, better known as PIP, has a substantial role to play.

Pour en savoir plus...

The promise that the COVID-19 vaccine brings: A hepatitis C nurse’s perspective

23 mars 2021 • Par Bernadette Lettner

Winding through the basement of the hospital, past the spin studio that has been closed for a long time, I follow the snaking line of people. I stand on my designated dot on the floor, a reminder of the physical distancing measures we’ve all grown accustomed to this past year. I go through registration, and then into another line, multiple staff directing me at every turn, ensuring we respect the space and flow in this most circuitous of marathons. I sit down beside a nurse, who goes through the consent form one last time, as she picks up the needle...

Pour en savoir plus...

Understanding prescribing trends for hepatitis C treatment in Ontario

24 février 2021 • Par Mary Guyton, RN, Jennifer Broad and Kate Mason

The introduction and wide availability of direct-acting antivirals (DAAs) as a treatment for hepatitis C through a phased rollout from 2015 to 2018 held the promise of expanded access to treatment. These simpler treatments carried fewer clinical restrictions and required less specialist support, opening the possibility for primary care providers to treat their patients with hepatitis C. Given barriers to healthcare access for people who use drugs, those of us at the Toronto Community Hep C Program were curious to find out if this had in fact happened.

Pour en savoir plus...